Trial Outcomes & Findings for Continuous Glucose Sensor Profiles in Non-Diabetic Subjects (NCT NCT00717977)

NCT ID: NCT00717977

Last Updated: 2016-10-19

Results Overview

Mean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average over all 24 hours.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

74 participants

Primary outcome timeframe

48-72 hours

Results posted on

2016-10-19

Participant Flow

The study was conducted at 10 adult and pediatric diabetes centers, after approval by their institutional review boards. Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an individual with type 1 diabetes.

Participant milestones

Participant milestones
Measure
All Non-Diabetic Subjects
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Overall Study
STARTED
74
Overall Study
COMPLETED
74
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Continuous Glucose Sensor Profiles in Non-Diabetic Subjects

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Age, Customized
8-<15 years
20 Participants
n=5 Participants
Age, Customized
15-<25 years
17 Participants
n=5 Participants
Age, Customized
25-<45 years
20 Participants
n=5 Participants
Age, Customized
>=45 years
17 Participants
n=5 Participants
Sex: Female, Male
Female
51 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic, Caucasian
55 Participant
n=5 Participants
Race/Ethnicity, Customized
Hispanic
13 Participant
n=5 Participants
Race/Ethnicity, Customized
African American
1 Participant
n=5 Participants
Race/Ethnicity, Customized
Other Race/Ethnicities
5 Participant
n=5 Participants
2-hour post-oral glucose tolerance test (OGTT)
96 mg/dL
STANDARD_DEVIATION 22 • n=5 Participants
Fasting Glucose
86 mg/dL
STANDARD_DEVIATION 8 • n=5 Participants
Hemoglobin A1c
All
5.3 Percent
STANDARD_DEVIATION 0.3 • n=5 Participants
Hemoglobin A1c
8-<15 years
5.3 Percent
STANDARD_DEVIATION 0.2 • n=5 Participants
Hemoglobin A1c
15-<25 years
5.2 Percent
STANDARD_DEVIATION 0.2 • n=5 Participants
Hemoglobin A1c
25-<45 years
5.2 Percent
STANDARD_DEVIATION 0.3 • n=5 Participants
Hemoglobin A1c
>=45 years
5.5 Percent
STANDARD_DEVIATION 0.3 • n=5 Participants

PRIMARY outcome

Timeframe: 48-72 hours

Mean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average over all 24 hours.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Overall Mean Sensor Glucose by Age Group
All
98 mg/dL
Standard Deviation 10
Overall Mean Sensor Glucose by Age Group
8-<15 years
103 mg/dL
Standard Deviation 11
Overall Mean Sensor Glucose by Age Group
15-<25 years
97 mg/dL
Standard Deviation 7
Overall Mean Sensor Glucose by Age Group
25-<45 years
96 mg/dL
Standard Deviation 12
Overall Mean Sensor Glucose by Age Group
>=45 years
95 mg/dL
Standard Deviation 7

PRIMARY outcome

Timeframe: 48-72 hours

Mean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average from 6 a.m. to midnight.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
All
99 mg/dL
Standard Deviation 10
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
8-<15 years
103 mg/dL
Standard Deviation 10
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
15-<25 years
98 mg/dL
Standard Deviation 7
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
25-<45 years
97 mg/dL
Standard Deviation 12
Daytime (6:00 a.m. - Midnight) Mean Sensor Glucose by Age Group
>=45 years
97 mg/dL
Standard Deviation 6

PRIMARY outcome

Timeframe: 48-72 hours

Mean glucose value was calculated for every hour of the 24 hours of the day. This measure is the average from midnight to 6 a.m.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
All
95 mg/dL
Standard Deviation 13
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
8-<15 years
101 mg/dL
Standard Deviation 15
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
15-<25 years
97 mg/dL
Standard Deviation 11
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
25-<45 years
91 mg/dL
Standard Deviation 12
Nighttime (Midnight - 6:00 a.m.) Mean Sensor Glucose by Age Group
>=45 years
89 mg/dL
Standard Deviation 11

PRIMARY outcome

Timeframe: 48-72 hours

The calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Peak Daytime Sensor Glucose Value by Age Group
All
131 mg/dL
Interval 121.0 to 140.0
Peak Daytime Sensor Glucose Value by Age Group
8-<15 years
134 mg/dL
Interval 128.0 to 145.0
Peak Daytime Sensor Glucose Value by Age Group
15-<25 years
135 mg/dL
Interval 119.0 to 144.0
Peak Daytime Sensor Glucose Value by Age Group
25-<45 years
125 mg/dL
Interval 118.0 to 134.0
Peak Daytime Sensor Glucose Value by Age Group
>=45 years
128 mg/dL
Interval 122.0 to 134.0

PRIMARY outcome

Timeframe: 48-72 hours

The calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Peak Nightime Sensor Glucose Value by Age Group
All
109 mg/dL
Interval 99.0 to 118.0
Peak Nightime Sensor Glucose Value by Age Group
8-<15 years
111 mg/dL
Interval 108.0 to 120.0
Peak Nightime Sensor Glucose Value by Age Group
15-<25 years
111 mg/dL
Interval 106.0 to 118.0
Peak Nightime Sensor Glucose Value by Age Group
25-<45 years
104 mg/dL
Interval 95.0 to 111.0
Peak Nightime Sensor Glucose Value by Age Group
>=45 years
103 mg/dL
Interval 97.0 to 113.0

PRIMARY outcome

Timeframe: 48-72 hours

The calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data. The daytime nadir reflects the lowest point on the sensor glucose curve registered among daytime values.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Daytime Nadir Sensor Glucose Value by Age Group
All
73 mg/dL
Interval 68.0 to 82.0
Daytime Nadir Sensor Glucose Value by Age Group
8-<15 Years
74 mg/dL
Interval 68.0 to 86.0
Daytime Nadir Sensor Glucose Value by Age Group
15-<25 Years
71 mg/dL
Interval 67.0 to 77.0
Daytime Nadir Sensor Glucose Value by Age Group
25-<45 Years
75 mg/dL
Interval 67.0 to 82.0
Daytime Nadir Sensor Glucose Value by Age Group
>=45 Years
79 mg/dL
Interval 68.0 to 84.0

PRIMARY outcome

Timeframe: 48-72 hours

The calculation of peak and nadir glucose was restricted to days with \>=12 hours and nights with \>=4 hours of sensor glucose data. The nighttime nadir reflects the lowest point on the sensor glucose curve registered among nighttime values.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Nighttime Nadir Sensor Glucose Value by Age Group
All
80 mg/dL
Interval 73.0 to 89.0
Nighttime Nadir Sensor Glucose Value by Age Group
5-<15 Years
84 mg/dL
Interval 78.0 to 91.0
Nighttime Nadir Sensor Glucose Value by Age Group
15-<25 Years
80 mg/dL
Interval 76.0 to 93.0
Nighttime Nadir Sensor Glucose Value by Age Group
25-<45 Years
77 mg/dL
Interval 67.0 to 88.0
Nighttime Nadir Sensor Glucose Value by Age Group
>=45 Years
78 mg/dL
Interval 78.0 to 86.0

PRIMARY outcome

Timeframe: 48-72 hours

The Percentage Sensor Glucose Levels between 71-120 mg/dL was calculated for each subject. The median and quartiles over all subjects were reported here.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
All
91.0 Percent
Interval 79.0 to 94.0
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
8-<15 Years
85.1 Percent
Interval 79.0 to 92.0
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
15-<25 Years
87.9 Percent
Interval 76.0 to 96.0
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
25-<45 Years
91.4 Percent
Interval 78.0 to 94.0
Percentage of Sensor Glucose Levels Between 71-120 mg/dL by Age Group
>=45 Years
93.7 Percent
Interval 88.0 to 95.0

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels 71-120 mg/dL by Time of Day
Daytime (6am-midnight)
90.4 Percent
Interval 80.0 to 95.0
Percentage of Sensor Glucose Levels 71-120 mg/dL by Time of Day
Nightime (midnight-6am)
90.3 Percent
Interval 76.0 to 98.0

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
All
1.7 Percent
Interval 0.0 to 7.2
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
8-<15 Years
1.8 Percent
Interval 0.0 to 4.3
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
15-<25 Years
0.6 Percent
Interval 0.0 to 8.1
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
25-<45 Years
2.9 Percent
Interval 0.0 to 8.1
Distribution of Sensor Glucose Levels <=70 mg/dL by Age Group
>=45 Years
1.6 Percent
Interval 0.0 to 6.3

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels <=70 mg/dl by Time of Day
Daytime (6am-midnight)
1.1 Percent
Interval 0.0 to 5.1
Percentage of Sensor Glucose Levels <=70 mg/dl by Time of Day
Nighttime (midnight-6am)
2.2 Percent
Interval 0.0 to 12.0

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
All
0.2 Percent
Interval 0.0 to 1.7
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
8-<15 Years
0.2 Percent
Interval 0.0 to 1.8
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
15-<25 Years
0.0 Percent
Interval 0.0 to 3.1
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
25-<45 Years
0.2 Percent
Interval 0.0 to 1.3
Percentage of Sensor Glucose Levels <=60 mg/dL by Age Group
>=45 Years
0.1 Percent
Interval 0.0 to 1.3

PRIMARY outcome

Timeframe: 48-72 hours

The Percentage of Sensor Glucose Levels \<=60 mg/dl was calculated for each subject separately for the daytime and nighttime period. The median and quartiles over all subjects were reported. Here the data is different with data analyzed by age group, which is a subgroup analysis on 'percentage of sensor glucose levels \<=60mg/dL' for all 24 hours.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels <=60 mg/dl by Time of Day
Daytime (6am-midnight)
0.0 Percent
Interval 0.0 to 1.2
Percentage of Sensor Glucose Levels <=60 mg/dl by Time of Day
Nighttime (midnight-6am)
0.0 Percent
Interval 0.0 to 1.3

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
All
5.6 Percent
Interval 2.2 to 9.3
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
8-<15 Years
8.2 Percent
Interval 5.6 to 16.0
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
15-<25 Years
8.3 Percent
Interval 3.1 to 13.0
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
25-<45 Years
4.2 Percent
Interval 1.8 to 7.1
Percentage of Sensor Glucose Levels >120 mg/dL by Age Group
>=45 Years
4.4 Percent
Interval 1.2 to 5.8

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels >120 mg/dl by Time of Day
Daytime (6am-midnight)
5.9 Percent
Interval 2.4 to 11.0
Percentage of Sensor Glucose Levels >120 mg/dl by Time of Day
Nighttime (midnight-6am)
1.1 Percent
Interval 0.0 to 11.0

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
All
0.4 Percent
Interval 0.0 to 1.7
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
5-<15 Years
1.3 Percent
Interval 0.3 to 3.7
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
15-<25 Years
0.3 Percent
Interval 0.0 to 1.5
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
25-<45 Years
0.3 Percent
Interval 0.0 to 1.9
Percentage of Sensor Glucose Levels >140 mg/dL by Age Group
>=45 Years
0.0 Percent
Interval 0.0 to 1.0

PRIMARY outcome

Timeframe: 48-72 hours

The Percentage of Sensor Glucose Levels \>140 mg/dl was calculated for each subject separately for the daytime and nighttime period. The median and quartiles over all subjects were reported. Here the data is different with data analyzed by age group, which is a subgroup analysis on 'percentage of sensor glucose levels \>140 mg/dl' for all 24 hours.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Percentage of Sensor Glucose Levels >140 mg/dl by Time of Day
Daytime (6am-midnight)
0.5 Percent
Interval 0.0 to 2.3
Percentage of Sensor Glucose Levels >140 mg/dl by Time of Day
Nighttime (midnight-6am)
0.0 Percent
Interval 0.0 to 0.0

PRIMARY outcome

Timeframe: 48-72 hours

Here, 'Standard Deviation' is a measure of glucose variability. This measure was calculated by taking the SD of all glucose values for each subject. Each subject has a SD value. The median and quartiles of this measure over all subjects were reported.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure- Standard Deviation by Age Group
All
13.7 mg/dL
Interval 11.4 to 18.0
Glucose Variability Measure- Standard Deviation by Age Group
8-<15 Years
16.4 mg/dL
Interval 13.2 to 19.1
Glucose Variability Measure- Standard Deviation by Age Group
15-<25 Years
13.7 mg/dL
Interval 11.1 to 19.9
Glucose Variability Measure- Standard Deviation by Age Group
25-<45 Years
12.6 mg/dL
Interval 12.1 to 16.5
Glucose Variability Measure- Standard Deviation by Age Group
>=45 Years
12.4 mg/dL
Interval 10.0 to 15.9

PRIMARY outcome

Timeframe: 48-72 hours

Here, 'Standard Deviation' is a measure of glucose variability. This measure was calculated by taking the SD of all glucose values for each subject. Each subject has a SD value. The median and quartiles of this measure over all subjects were reported.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure- Standard Deviation by Time of Day
Daytime (6am-midnight)
13.5 mg/dL
Interval 11.3 to 17.8
Glucose Variability Measure- Standard Deviation by Time of Day
Nighttime (midnight-6am)
10.9 mg/dL
Interval 8.2 to 16.8

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure- Absolute Rate of Change by Age Group
All
0.34 mg/dL/min
Interval 0.3 to 0.41
Glucose Variability Measure- Absolute Rate of Change by Age Group
8-<15 Years
0.36 mg/dL/min
Interval 0.36 to 0.46
Glucose Variability Measure- Absolute Rate of Change by Age Group
15-<25 Years
0.34 mg/dL/min
Interval 0.3 to 0.39
Glucose Variability Measure- Absolute Rate of Change by Age Group
25-<45 Years
0.32 mg/dL/min
Interval 0.28 to 0.37
Glucose Variability Measure- Absolute Rate of Change by Age Group
>=45 Years
0.33 mg/dL/min
Interval 0.24 to 0.41

PRIMARY outcome

Timeframe: 48-72 hours

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure- Absolute Rate of Change by Time of Day
Daytime (6am-midnight)
0.37 mg/dL/min
Interval 0.32 to 0.43
Glucose Variability Measure- Absolute Rate of Change by Time of Day
Nighttime (midnight-6am)
0.26 mg/dL/min
Interval 0.18 to 0.35

PRIMARY outcome

Timeframe: 48-72 hours

The Coefficient of Variation is calculated by dividing the standard deviation by the mean glucose. Each subject received a SD value. The median and quartiles of this measure over all subjects were reported.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure- Coefficient of Variation by Age Group
All
14 Percent
Interval 12.0 to 19.0
Glucose Variability Measure- Coefficient of Variation by Age Group
8-<15 Years
16 Percent
Interval 13.0 to 19.0
Glucose Variability Measure- Coefficient of Variation by Age Group
15-<25 Years
14 Percent
Interval 12.0 to 21.0
Glucose Variability Measure- Coefficient of Variation by Age Group
25-<45 Years
14 Percent
Interval 13.0 to 17.0
Glucose Variability Measure- Coefficient of Variation by Age Group
>=45 Years
13 Percent
Interval 10.0 to 16.0

PRIMARY outcome

Timeframe: 48-72 hours

The Coefficient of Variation is calculated by dividing the standard deviation by the mean glucose. Each subject received a SD value. The median and quartiles of this measure over all subjects were reported.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure- Coefficient of Variation by Time of Day
Daytime (6am-midnight)
14 Percent
Interval 12.0 to 18.0
Glucose Variability Measure- Coefficient of Variation by Time of Day
Nighttime (midnight-6am)
12 Percent
Interval 9.0 to 19.0

PRIMARY outcome

Timeframe: 48-72 hours

The Mean Amplitude of Glycemic Excursions also known as MAGE depicts the upward and downward acute glucose fluctuations seen in the sensor data.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
All
27.7 mg/dL
Interval 23.1 to 33.1
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
8-<15 Years
28.1 mg/dL
Interval 23.9 to 33.2
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
15-<25 Years
28.3 mg/dL
Interval 25.1 to 33.1
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
25-<45 Years
25.6 mg/dL
Interval 22.8 to 31.4
Glucose Variability Measure: Mean Amplitude of Glycemic Excursions by Age Group
>=45 Years
26.9 mg/dL
Interval 21.4 to 34.1

PRIMARY outcome

Timeframe: 48-72 hours

The Mean Amplitude of Glycemic Excursions also known as MAGE depicts the upward and downward acute glucose fluctuations seen in the sensor data.

Outcome measures

Outcome measures
Measure
All Non-Diabetic Subjects
n=74 Participants
Subjects were healthy adults, adolescents, and children who were clinic staff, friends, relatives of clinic staff, or relatives or acquaintances of an indiviual with type 1 diabetes.
Glucose Variability Measure: Amplitude of Glycemic Excursions by Time of Day
Daytime (6am-midnight)
28.0 mg/dL
Interval 23.8 to 31.9
Glucose Variability Measure: Amplitude of Glycemic Excursions by Time of Day
Nighttime (midnight-6am)
15.8 mg/dL
Interval 12.3 to 20.3

Adverse Events

All Non-Diabetic Subjects

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Roy W. Beck, M.D., Ph.D.

Jaeb Center for Health Research

Phone: 813-975-8690

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60